Edge Capital Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $1.49M | Buy |
2,862
+197
| +7% | +$102K | 0.07% | 144 |
|
2024
Q3 | $1.65M | Sell |
2,665
-38
| -1% | -$23.5K | 0.07% | 133 |
|
2024
Q2 | $1.49M | Hold |
2,703
| – | – | 0.07% | 138 |
|
2024
Q1 | $1.57M | Buy |
2,703
+113
| +4% | +$65.7K | 0.08% | 134 |
|
2023
Q4 | $1.37M | Buy |
2,590
+122
| +5% | +$64.8K | 0.08% | 143 |
|
2023
Q3 | $1.25M | Hold |
2,468
| – | – | 0.08% | 140 |
|
2023
Q2 | $1.29M | Sell |
2,468
-134
| -5% | -$69.9K | 0.07% | 158 |
|
2023
Q1 | $1.5M | Sell |
2,602
-1,364
| -34% | -$786K | 0.09% | 143 |
|
2022
Q4 | $2.18M | Buy |
3,966
+862
| +28% | +$475K | 0.15% | 103 |
|
2022
Q3 | $1.57M | Sell |
3,104
-11
| -0.4% | -$5.58K | 0.13% | 108 |
|
2022
Q2 | $1.69M | Buy |
3,115
+44
| +1% | +$23.9K | 0.15% | 111 |
|
2022
Q1 | $1.81M | Sell |
3,071
-114
| -4% | -$67.3K | 0.12% | 111 |
|
2021
Q4 | $2.13M | Sell |
3,185
-29
| -0.9% | -$19.3K | 0.15% | 104 |
|
2021
Q3 | $1.84M | Sell |
3,214
-101
| -3% | -$57.7K | 0.15% | 106 |
|
2021
Q2 | $1.67M | Sell |
3,315
-29
| -0.9% | -$14.6K | 0.13% | 110 |
|
2021
Q1 | $1.53M | Sell |
3,344
-200
| -6% | -$91.3K | 0.13% | 107 |
|
2020
Q4 | $1.65M | Buy |
3,544
+59
| +2% | +$27.5K | 0.14% | 106 |
|
2020
Q3 | $1.54M | Sell |
3,485
-175
| -5% | -$77.3K | 0.15% | 102 |
|
2020
Q2 | $1.33M | Buy |
3,660
+60
| +2% | +$21.7K | 0.14% | 105 |
|
2020
Q1 | $1.02M | Sell |
3,600
-48
| -1% | -$13.6K | 0.12% | 110 |
|
2019
Q4 | $1.19M | Hold |
3,648
| – | – | 0.12% | 111 |
|
2019
Q3 | $1.06M | Sell |
3,648
-413
| -10% | -$120K | 0.11% | 114 |
|
2019
Q2 | $1.19M | Buy |
4,061
+466
| +13% | +$137K | 0.11% | 113 |
|
2019
Q1 | $984K | Sell |
3,595
-330
| -8% | -$90.3K | 0.1% | 121 |
|
2018
Q4 | $878K | Buy |
+3,925
| New | +$878K | 0.1% | 113 |
|